NCT00875602

Brief Summary

Evaluation of continuous monitoring device on patients Risk during hospitalization and nurse satisfaction level.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 3, 2009

Completed
Last Updated

December 6, 2016

Status Verified

October 1, 2012

First QC Date

April 2, 2009

Last Update Submit

December 5, 2016

Conditions

Keywords

All hospitalized patients in a general Med/ Surg unit

Outcome Measures

Primary Outcomes (1)

  • Evidence of benefit to caregivers and patients

    12 month

Study Arms (2)

control

NO INTERVENTION

before-after (retrospective) and concurrent controls as comparators with a prospective intervention group

Study unit

ACTIVE COMPARATOR

Hospitalized patients in the study group will be continously monitored / supervised by the contact-free device

Device: EverOn (EarlySense) contactless monitoring device

Interventions

Hospitalized patients on the study unit are monitored by a contactless device

Study unit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized patients

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHMC

Los Angeles, California, 90015, United States

Location

MeSH Terms

Conditions

Death

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Harvey V Brown, MD

    CHW

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2009

First Posted

April 3, 2009

Study Start

April 1, 2009

Last Updated

December 6, 2016

Record last verified: 2012-10

Locations